By Donald Zuhn —

During yesterday's press conference announcing the introduction of new patent reform legislation in both the Senate and House, Senate Judiciary Committee Chairman Patrick Leahy (D-VT) noted that the Senate Judiciary Committee would be holding a hearing on patent reform next week. The hearing, entitled "Patent Reform in the 111th Congress: Legislation and Recent Court Decisions" will take place on March 10th at 10:00 AM (Eastern).
Today, the Senate Judiciary Committee released a witness list for the hearing. Among the witnesses scheduled to appear before the Committee are:
• Philip Johnson, Chief Intellectual Property Counsel for Johnson & Johnson;
• David Kappos, Vice President and Assistant General Counsel of Intellectual Property Law and Strategy for International Business Machines Corporation;
• Taraneh Maghame, Vice President of Tessera, Inc.;
• Herbert Wamsley, Executive Director for the Intellectual Property Owners Association; and
• Mark Lemley, the William H. Neukom Professor of Law at Stanford Law School.
For biotech and pharma patent applicants and practitioners, the list seems a little imbalanced as only one of the witnesses (Philip Johnson of Johnson & Johnson) has any connection with the life sciences industry.
A live webcast of the hearing will be broadcast on the Committee's website.

Leave a comment